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Abstract: Moonlighting proteins can perform one or more additional functions besides their primary
role. It has been posited that a protein can acquire a moonlighting function through a gradual
evolutionary process, which is favored when the primary and secondary functions are exerted
in different cellular compartments. Transcription factors (TFs) and splicing factors (SFs) control
processes that occur in interphase nuclei and are strongly reduced during cell division, and are
therefore in a favorable situation to evolve moonlighting mitotic functions. However, recently
published moonlighting protein databases, which comprise almost 400 proteins, do not include
TFs and SFs with secondary mitotic functions. We searched the literature and found several TFs
and SFs with bona fide moonlighting mitotic functions, namely they localize to specific mitotic
structure(s), interact with proteins enriched in the same structure(s), and are required for proper
morphology and functioning of the structure(s). In addition, we describe TFs and SFs that localize to
mitotic structures but cannot be classified as moonlighting proteins due to insufficient data on their
biochemical interactions and mitotic roles. Nevertheless, we hypothesize that most TFs and SFs with
specific mitotic localizations have either minor or redundant moonlighting functions, or are evolving
towards the acquisition of these functions.
Keywords: transcription factors; splicing factors; multifunctional proteins; protein moonlighting;
mitosis; microtubules; spindle; centrosomes; kinetochores; midbody
1. Introduction
In 1999, Constance J. Jeffrey, coined the term “moonlighting protein” to describe a protein that
performs one or more additional functions besides its canonical one [1]. Moonlighting proteins
play roles in many different biological processes. Recently published manually curated databases
(MoonProt 2.0 and MoonDB 2.0) describe almost 400 moonlighting proteins [2,3] and new bifunctional
and multifunctional proteins are continuously discovered.
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The coexistence of more than one activity in a single protein is the likely result of a gradual
evolutionary transition from the original function to a novel function. It has been further posited
that protein moonlighting is favored when the novel and the canonical function are exerted in
different cellular compartments, and/or in combination with different binding partners, so as to avoid
functional conflicts [1,4,5]. Under this view, mitosis seems to be an ideal process to favor acquisition
of moonlighting functions, as it is characterized by a dramatic rearrangement of cell structures,
accompanied by re-localization and compartmentalization of many proteins. For example, during
chromosome condensation, many chromatin proteins are released in the cytoplasm and re-associate
with the chromatin only when chromosomes decondense during telophase. Some of these proteins
have acquired moonlighting mitotic functions [6,7]. The ISWI and CHD4 chromatin remodeling factors
bind the spindle microtubules (MTs) in both Drosophila S2 cells and Xenopus cells and egg extracts,
and are required for spindle assembly and functioning [8,9]. Similarly, the human INO80 ATPase,
involved in both DNA replication and chromatin remodeling, binds the mitotic spindle and is required
for chromosome segregation [10,11]. Thus, the mitotic spindle can bind and compartmentalize proteins
that during interphase are associated with the chromatin and reside within the nucleus.
During mitosis, several cellular processes such as transcription and splicing are strongly
reduced [12–14], and therefore the proteins involved in these processes are in a very favorable
situation to evolve secondary mitotic functions. Indeed, several genome-wide screens carried out in
Drosophila and human cells have shown that RNAi-mediated depletion of many different transcription
factors (TFs) and splicing factors (SFs) results in a variety of mitotic defects [15–20] (see Tables S1 and
S2). Other TFs and SFs required for mitotic division have been identified in studies on specific proteins
or protein complexes (see Tables 1 and 2 and text below). However, in most cases, it is unclear whether
the TF- or SF-dependent mitotic phenotype is due to a direct (moonlighting) function of the factor,
or to an indirect effect on transcription or splicing of one or more mRNAs encoding mitotic proteins
(henceforth, mitotic mRNAs).
In this review, we analyze the literature on the mitotic roles of TFs and SFs. We include in our TF
category not only the canonical DNA binding factors, but also the proteins that regulate transcription
without binding to DNA (e.g., co-activators and co-repressors) [21]. Similarly, we consider as SFs
both the proteins complexed with small nuclear RNAs (snRNAs) and the proteins that do not directly
interact with these RNAs but are required for splicing [22]. We report many examples of TFs and SFs
that in addition to their canonical function in transcription and splicing, play moonlighting mitotic
roles, as well as cases where the TFs and SFs appear to have indirect mitotic effects controlling the
biogenesis of mitotic mRNAs. Defining whether a factor associated with a loss-of-function mitotic
phenotype has a direct mitotic role is not straightforward. We classify a TF/SF as a moonlighting
mitotic protein when it meets at least three conditions: (i) it localizes to a specific mitotic structure,
(ii) biochemically interacts with proteins enriched in the same structure, and (iii) causes defects in this
structure upon depletion. Conversely, a TF/SF is classified as an indirect mitotic player when it does
not exhibit a mitotic localization and there is biochemical evidence that its loss impairs transcription
or splicing of genes encoding mitotic proteins specifically related to the affected mitotic structure.
However, for many TFs/SFs that localize to mitotic structures, published information is not sufficient to
decide whether they play a direct function during cell division. For example, for some of these factors,
there is no information on their biochemical interactions or loss-of-function mitotic phenotype, while
knockdown of other factors does not appear to elicit a clear mitotic phenotype. Thus, we classify this
heterogeneous group of TFs/SFs as factors with a “putatively direct” mitotic function (Tables 1 and 2),
whose precise assessment requires further investigation.
Overall, we provide a large but non-exhaustive list of TFs and SFs with mitotic functions and
critically analyze their mitotic roles. We would like to point out that none of the TFs and SFs with direct
mitotic roles (see Tables 1 and 2 below) are included in the extant moonlighting protein databases [2,3].
Cells 2020, 9, 1554 3 of 27
2. Transcription Factors (TFs) with Mitotic Functions
2.1. TFs That Control Mitosis by Regulating the Expression of Mitotic Genes
Several TFs are thought to affect mitosis indirectly through the regulation of transcription or
stability of mitotic mRNAs. Forkhead transcription factors (FKH-TFs) have been implicated in the
regulation of mitotic gene transcription in both yeast and humans [23,24]. In humans, FKH-TFs (e.g.,
FOXO3) regulate the expression of mitotic genes such as cyclin B1 (CCNB1) and reductions in the
activities of FKH-TFs result in delayed M-G1 transition and defective cytokinesis [23]. In S. pombe,
most of the mitotic gene promoters targeted by FKH-TFs (e.g., Fkh2) are additionally associated with
Sak1, a TF of the RFX family that also appears to control mitosis indirectly [24] (Table 1).
Another TF that is thought to have an indirect mitotic function is Zas1 of S. pombe, which
controls the expression of a specific set of genes involved in cell division, including the gene encoding
the Cnd1 subunit of the condensin complex [25]. Mutations in Zas1 cause defects in chromosome
condensation and segregation, but these defects are not fully rescued by expression of the Cnd1
protein. This finding has led to the suggestion that the mitotic phenotype elicited by Zas1 deficiency
might be the consequence of the simultaneous deregulation of multiple mitotic genes [25]. However,
the observation that Zas1 remains associated with the chromosomes throughout mitosis, and that this
association is essential for its mitotic function [25], does not exclude the possibility that Zas1 directly
participates in the chromosome condensation process.
A peculiar form of indirect mitotic regulation is exerted by the ERG transcription factor of the
ETS family. In addition to the nucleus, ERG accumulates in cytoplasmic messenger ribonucleoprotein
(mRNP) aggregates called processing bodies (PBs), which contain the RNA degradation machinery.
Consistent with this localization, ERG promotes mRNA decay by binding the CCR4–NOT deadenylation
complex. ERG depletion in HeLa cells results in impaired degradation of a subset of mRNAs including
those encoding the Aurora kinase A (AURKA) and Aurora kinase B (AURKB). Accumulation of these
kinases deregulates Aurora signaling, resulting in a variety of mitotic defects, including centrosome
fragmentation, morphologically abnormal bipolar spindles and multipolar spindles [26].
2.2. TFs That Localize to Centrosomes
There are many TFs that accumulate at the centrosomes (Table 1; Figure 1). The centrosomes are
self-assembling organelles that nucleate the spindle MTs during cell division. They are comprised
of a pair of orthogonally arranged rod-like centrioles surrounded by pericentriolar material (PCM),
which contains several proteins necessary for MT nucleation, including γ-tubulin (TUBG1) [27,28].
In mammals, a centriole pair consists of a mother centriole characterized by the presence of subdistal
appendages, and a younger daughter centriole that grows from the mother during interphase; the two
centrioles remain attached to each other until anaphase, when they are disengaged by separase [27].
Some TFs meet our three criteria for a moonlighting function at the centrosomes, namely they localize
to the centrosomes, physically interact with centrosomal proteins and are required for centrosome
structure, duplication, or MT nucleation activity. Other TFs meet only one or two of these three criteria,
and it is therefore currently unclear whether they play direct functions at the centrosomes.
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 Figure 1. Localization of transcription and splicing factors to mitotic structures of metaphase (top) and
late telophase (bottom) cells. Data are from human (h), mouse (m), Drosophila (Dm), and S. pombe (Sp)
cells and from spindles assembled in Xenopus egg extracts (Xe). Protein localization in the schematic
metaphase is also observed in prometaphases and anaphases. Likewise, the protein localization pattern
in the schematic late telophase is comparable to that seen in earlier stages of telophase. Of the proteins
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that localize to the centrosomes, most are present from prophase to telophase, but some (depicted in
green) are not detected in telophase centrosomes. For other centrosomal proteins (marked by an asterisk),
lack of pertinent images did not permit an assessment of their presence in telophase centrosomes.
The midbody at the center of the cellular bridge consists of a dark zone that contains interdigitating
antiparallel MTs associated with several proteins, including centralspindlin (MKLP1/KIF23 and
CYK4/RACGAP1), CIT-K, KIF14, and anillin. These and other proteins form a dense cluster (midbody
ring) that impedes access of anti-tubulin antibodies, resulting in a dark zone after immunostaining.
The flanking regions also contain several proteins, including those of the ESCRT machinery that
mediates abscission, which can occur at either side of the dark zone. Localization of some proteins is
phosphorylation (P+), dephosphorylation (P−), or desumoylation (SUMO−) dependent.
An example of a moonlighting TF with a centrosomal function is the well-known tumor suppressor
BRCA1. BRCA1 is a multifunctional protein that is included in several different complexes primarily
involved in DNA replication and repair. BRCA1 can also associate with the RNA polymerase II
holoenzyme and some well-known TFs (TFIIF/GTF2F1, TFIIE/GTF2E1, and TFIIH/GTF2H1; here and
henceforth, the commonly used abbreviation for a human protein and its HUGO-based symbol are
separated by a slash), acting as a transcriptional regulator [29,30]. In addition, BRCA1 is enriched at
the centrosomes where it interacts with the BRCA1-associated RING domain protein (BARD1) and
the Obg-like ATPase 1 (OLA1) to form a complex with E3 ligase activity that binds and ubiquitinates
γ-tubulin [31–35]. BRCA1 downregulation causes centrosome amplification and fragmentation in cell
lines from mammary tissues [36,37] and in mouse embryonic fibroblast cells [38]. The localization of
BRCA1 at the centrosome, its biochemical interaction with γ-tubulin, and the centrosomal phenotype
elicited by its deficiency strongly suggest that BRCA1 is directly involved in centrosome maintenance.
The evolutionarily conserved BRCA1 protein is also required for spindle formation induced by
sperm nuclei in cytoplasmic extracts from Xenopus laevis eggs. In this system [39], BRCA1 is slightly
enriched at the spindle poles and physically interacts with BARD1 and the spindle-associated proteins
TPX2, NuMa, and XRHAMM. BRCA1 immunodepletion results in morphologically aberrant spindles
with unfocused poles and a higher MT density compared to spindles formed in BRCA1-nondepleted
extracts [40]. Because Xenopus egg extracts can support mitosis independently of transcription and
translation, requiring only synthesis of cyclin B [41,42], these findings strongly suggest that BRCA1
directly contributes to centrosome-independent spindle assembly in this in vitro system.
Another remarkable example of a TF with a moonlighting role in centrosome assembly and
function is ATF5, a member of the ATF/CREB family of TFs [43]. In human cells, ATF5 accumulates
at the centrosomes from G1 through anaphase and dissociates from the centrosomes during late
telophase. Consistent with its subcellular localization, ATF5 interacts with multiple centrosomal
proteins, including γ-tubulin and pericentrin (PCNT), and is specifically enriched in a cylindrical
structure that encircles the proximal end of the mother centriole [44]. ATF5 association with the
centrosomes is regulated by SUMOylation; SUMOylated ATF5 does not localize to centrosomes
and does not interact with centrosomal proteins [45]. RNAi-mediated downregulation of ATF5
results in impaired centrosomal accumulation of PCM components such as γ-tubulin and PCNT,
centriolar fragmentation and formation of multipolar spindles [44]. Interestingly, during late telophase,
ATF5 dissociates from centrosomes and accumulates in the midbody [44], the structure in the middle
of the bridge that connects the daughter cells during completion of cytokinesis (Figure 1). However,
the ATF5 functional role at the midbody, if any, is currently unknown. The midbody forms when
the overlapping plus ends of the central spindle MTs are compacted by cytokinetic ring constriction,
so as to form a MT-dense region, called dark zone, associated with multiple proteins that impede
staining with anti-tubulin antibodies [46,47]. The midbody has a defined protein composition and
substructure [47,48], but here we will only refer to the dark zone (DZ) and its flanking regions (FR),
because these are the only regions we can appreciate in published figures of late telophases stained for
both tubulin and the TF or SF under study (Figure 1).
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Another integral centriolar component is AKNA, an AT-hook TF that is required for neurogenesis
in mouse brain [49]. Like ATF5, AKNA localizes to the mother centriole, where it is mostly enriched at
the subdistal appendages. In contrast with the ATF5 behavior, AKNA dissociates from centrosomes
during mitosis upon increased phosphorylation and re-associates with the centrosomes during late
telophase/early G1. AKNA recruits and physically interacts with components of the γ-tubulin
ring complex (γTuRC), and MT binding proteins such as EB1, P150-Glued (DCTN1), and dynein.
RNAi-mediatedAKNA knockdown results in a significant reduction in centrosome-driven MT regrowth
after MT depolymerization with nocodazole, but it is unclear whether this defect underlies a gross
alteration in normal spindle assembly [49].
Additional TFs that are likely to play moonlighting functions at the centrosomes are the
Y-box binding protein-1 (YB-1/YBX1) and OCT1/POU2F1. YB-1, which is overexpressed in many
cancers, has roles in transcription, translation, and splicing, localizes to the centrosomes of human
cells in a phosphorylation-dependent manner, and physically interacts with γ-tubulin and PCNT.
In YB-1-depleted cells, centrosomes are structurally abnormal and have reduced MT nucleation
ability [50,51]. OCT1 is a well-known TF that regulates metabolism and tumorigenicity in humans
and mice. Upon phosphorylation in its DNA binding domain, OCT1 localizes to the centrosomes,
the central spindle and the midbody dark zone, and to a lesser extent to the kinetochores ([52] and
references therein). OCT1 interacts with proteins that are also found in the centrosomes such as
BRCA1 [53,54] and PARP-1 [55]. RNAi-mediated OCT1 depletion in HeLa cells results in abnormal
mitosis. Similarly, immunodepletion of the OCT1 ortholog from Xenopus egg extracts causes defects
in spindle assembly, a finding that provides further support for a moonlighting mitotic function of
OCT1 [52]. The OCT1 Drosophila ortholog, Nubbin, does not appear to localize to centrosomes but is
enriched at both the central spindle and the midbody flanking regions [56] (Figure 1). It is currently
unknown whether OCT1 and Nubbin have roles in cytokinesis [52,56].
There are several additional TFs that localize to the centrosomes, but it is currently unclear whether
they play direct functions in these structures. One of these TFs is the intensively studied p53/TP53
protein that plays crucial roles in the maintenance of genome stability and tumor suppression [57].
p53 controls transcription of genes involved in a variety of cellular processes, including cell cycle, DNA
repair, senescence, apoptosis, and autophagy, but also has direct cytoplasmic roles in mitochondrial
membrane permeabilization, apoptosis, and possibly autophagy inhibition [57]. p53 localizes to the
centrosomes in a variety of human, chicken, and rodent cells [58–60]; in human cells, centrosomal
localization of p53 is phosphorylation-dependent [61]. Loss of p53 results in centrosome amplification
in both human and mouse cells [62–66]. Interestingly, recent work has shown that p53 depletion
in human non-transformed cells results in centrosome fragmentation [67]. However, centrosome
fragmentation was not observed in p53-deficient mouse cells and human cancer cells, which instead
showed centrosome amplification [67], as previously described [65]. Although it has been suggested that
p53 might directly contribute to prevention of centrosome amplification [64,65] or fragmentation [67],
a compelling evidence for a moonlighting role of p53 at the centrosome is still lacking.
Other TFs that accumulate at the centrosomes of mammalian cells, but do not fit our three criteria
for a moonlighting centrosomal function are SP1, SF-1/NR5A1, Kaiso/ZBTB33, CTCF, SNAP45/SNAPC2,
and ELK1. SP1, which has been implicated in tumorigenesis, localizes to the centrosomes of mouse
and human cells and its loss causes centrosome amplification and decreased centrosome-driven MT
nucleation [68]. It has been suggested that SP1 deficiency results in the activation of TORC1 signaling,
which leads to centrosome amplification [68]. SF-1 prevents centrosome overduplication in mouse cells;
SF-1 depletion leads to an aberrant centrosomal accumulation and activation of the DNA-dependent
protein kinase catalytic subunit (DNA-PKcs), which is thought to activate the AKT-dependent signaling
cascade that leads to centrosome amplification [69,70]. Kaiso is a BTB/POZ zinc finger protein that acts
as a transcriptional repressor; in human cells, it localizes to the centrosomes, the spindle, the central
spindle, and the midbody flanking regions (Figure 1), and interacts with both γ-tubulin and PCNT.
However, loss of Kaiso does not cause obvious centrosome or mitotic defects [71,72]. CTCF is a
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transcriptional regulator that physically interacts with Kaiso [73]; it localizes to the centrosomes,
the spindle poles and the midbody dark zone in HeLa cells (Figure 1), but the mitotic effects of its
depletion were not investigated [74]. SNAP45, a TF required for transcription of snRNA genes, localizes
to the centrosomes, the spindle poles, and the midbody flanking regions (Figure 1). In HeLa cells,
RNAi-mediated depletion of SNAP45 leads to multiple mitotic defects, including morphologically
abnormal spindles and defective chromosome segregation. These aberrant mitotic phenotypes are at
least in part the consequence of additional primary defects in chromosome condensation and sister
chromatid pairing at metaphase [75]. Phosphorylated ELK1 localizes to the centrosomes, the spindle,
the central spindle, and the midbody flanking regions in human cells [76] (Figure 1). ELK1 physically
interacts with Aurora A [76], and its loss causes mitotic delay but no obvious mitotic defects [20].
The Runt-related TFs (RUNX1, RUNX2, and RUNX3) are important developmental regulators
with roles in carcinogenesis [77]. They also have multiple mitotic roles, but it is currently unclear
whether some of these roles are direct. Human RUNX1 positively regulates transcription of genes
encoding components of the spindle assembly checkpoint (SAC) machinery such as BUBR1/BUB1B,
BUB1, and NEK6 [78]. During human cell mitosis, following RUNX3 phosphorylation, the RUNX
proteins localize to the centrosomes and the midbody flanking regions [79] (see Figure 1 for mitotic
localization of individual RUNX proteins). It has been also shown that the RUNX factors co-precipitate
with centrosomal proteins such as γ-tubulin and the centriolar component rootletin (CROCC) [80].
However, individual depletion of each of the RUNX proteins results in reduced cyclin B1 accumulation
and delayed mitotic entry, but does not cause specific centrosome-related mitotic defects [79,80].
Several proteomic studies have shown that the centrosomes contain hundreds of different proteins,
but only a fraction of them (approximately one fourth) is known to be involved in centriole structure
and duplication or PCM-driven MT nucleation [81–83]. The functions of the centrosome-associated
proteins that do not appear to be involved in centrosome activity, such as p53, SP1, SF-1, Kaiso, CTCF,
ELK1, and RUNX TFs, are unclear. It cannot be excluded that some of these proteins play an as
yet undefined direct function required for proper centrosome behavior. Alternatively, it is possible
that their localization and accumulation in the centrosome helps them to interact with other proteins
hosted in this subcellular structure, or to keep them sequestered until they become necessary for
certain cellular processes. Recent work has provided some clues on how proteins without direct
centrosome-specific functions can concentrate in this organelle. It has been suggested that centrosome
assembly is facilitated by the ability of several centrosomal proteins to undergo liquid–liquid phase
transition and form liquid-like droplets that concentrate cytoplasmic components and then fuse to
form the PCM around the centrioles [84]. These droplets may include cytoplasmic proteins that will
become spurious centrosome components.
Interestingly, the centrosomes harbor several proteins involved in the DNA damage response
(DDR), including the ATM, ATR, CHK1, and CHK2 kinases [85]. The ATM and ATR kinases are
recruited to the sites of DNA damage and initiate a signaling cascade by phosphorylating the effector
CHK1 and CHK2 kinases, ultimately leading to p53 activation [57,85]. There is evidence that DNA
damage causes aberrant centriole disengagement, leading to centrosome amplification ([85] and
references therein), a condition that is thought to promote tumor initiation and progression [86].
However, it remains unclear whether the centrosomal fractions of the DDR kinases and p53 have roles
in DNA damage signaling and/or centrosome amplification.
2.3. TFs with Moonlighting Functions at the Midbody
Many of the TFs that concentrate in the centrosomes are also enriched at the midbody. For example,
ATF5, OCT1, and CTCF accumulate in the midbody dark zone, while SNAP45, ELK1, RUNX3, and
Kaiso localize to regions that flank the dark zone (Table 1; Figure 1). The possible roles of these proteins
in cytokinesis have not been thoroughly investigated. Thus, the reason for their double localization is
intriguing but currently unknown. These proteins might play some direct functions in completion of
cytokinesis, but it is also possible that they are hosted in the midbody without affecting cytokinesis.
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In this respect, it is worth noting that proteomic analysis of isolated midbodies has detected many
proteins with no obvious roles in the cytokinetic process [87].
However, the core binding factor β (CBFβ/CBFB) and the YAP/YAP1 transcriptional regulator,
appear to play moonlighting functions in cytokinesis. In human cells, CBFβ accumulates in the flanking
regions of the midbody and co-precipitates with the RUNX TFs and the myosin regulatory light chain
3 (MRLC3/MYL12A) [88]. RNAi-mediated depletion of CBFβ or overexpression of the CBFβ-SMMHC
(smooth muscle myosin heavy chain) leukemogenic fusion protein results in midbody abnormalities
and mislocalization of PRC1 [88]. PRC1 cross-links antiparallel MTs in the midbody and is essential
for completion of cytokinesis [89]. YAP is an interacting partner of the human RUNX proteins that
accumulate in the midbody dark zone. YAP is phosphorylated during mitosis and this modification is
essential for its function in cytokinesis. YAP co-precipitates with the polarity scaffold protein PATJ that
is also enriched in the midbody dark zone and whose knockdown phenocopies the abscission defect
elicited by YAP depletion [90]. Thus, although there is no compelling evidence for a role of the RUNX
proteins in cytokinesis, the RUNX interacting partners CBFβ and YAP appear to have moonlighting
functions in completion of cytokinesis.
2.4. TFs That Localize to the Spindle
Many TFs associate with interphase MTs and this association is thought to regulate TF ingress into
the nucleus [91]. For example, it has been reported that p53 binds to MTs and is actively transported
towards the nucleus in a dynein-dependent manner [92]. Other TFs exhibit a robust association
with the spindle MTs, and some of them appear to have moonlighting mitotic functions. One of
these factors is autoimmune regulator (Aire), a non-canonical TF involved in the immune tolerance
processes [93]. Aire associates with the metaphase spindles and ana-telophase central spindles of
mouse embryonic stem (mES) cells, and physically interacts with several spindle proteins including
AURKB, the centrosomal proteins CEP55 and centrobin (CNTROB), the augmin-like proteins HAUS5
and HAUS8, and the CLASP1 and CLASP2 regulators of MT dynamics [94]. Aire conditional (floxed)
knockout revealed that Aire loss results in morphologically abnormal spindle poles and centrosome
amplification in mES cells [94]. These results strongly suggest that Aire has a moonlighting mitotic
function but the mechanisms by which Aire controls spindle assembly and centrosome number remain
to be determined.
Other transcriptional regulators with possible direct mitotic functions are the components of
multiprotein complexes containing histone deacetylase 3 (HDAC3), which repress transcription [95].
HDAC3, the nuclear receptor corepressor (N-CoR/NCOR1), the transducin-β-like protein 1
(TBL1/TBL1X), and the TBL1-related protein 1 (TBLR1/TBL1XR1) all associate with the metaphase and
anaphase spindles, but not with telophase spindles; RNAi-mediated depletion of either HDAC3 or
N-CoR results in morphologically abnormal spindles and chromosome misalignment in HeLa cells [96].
It has been also shown that these mitotic defects are a specific consequence of disruption of HDAC3
deacetylase activity, whereas they are not elicited by treatment with the RNA polymerase II inhibitor
α-amanitin [96]. Thus, even if there is no compelling evidence for a direct physical interaction of the
HDAC3-associated proteins with spindle components, the extant data suggest that HDAC3 regulates
mitotic spindle formation in a transcription-independent manner.
Two additional TFs with roles in spindle assembly are mouse Egr3 and TFIIB, which associate with
the meiotic spindles of mouse females. Egr3 localizes to the spindles, but does not appear to interact
with MTs, and its function in meiotic division has not been investigated [97]. TFIIB also localizes
to meiotic spindles; RNAi against TFIIB or anti-TFIIB antibody injection into the oocyte results in
morphologically abnormal spindles and chromosome misalignment. However, there are no data on
biochemical interactions between TFIIB and spindle components [98]. Thus, current results do not
allow a conclusion on whether Egr3 and TFIIB play direct roles in meiotic spindle assembly.
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2.5. TFs with Roles in the Spindle Assembly Checkpoint (SAC)
TFs have been also implicated in the assembly and functioning of the SAC machinery. Several
TFs have been shown to regulate transcription of the SAC components. As mentioned earlier, loss of
RUNX1 negatively affects transcription of the BUB1 and NEK6 SAC genes [78]. Furthermore, BRCA1
knockdown in human cancer cells downregulates transcription of multiple mitotic genes, including
the BUB1, BUBR1/BUB1B, AURKA, ESPL1, and PTTG1 SAC genes [99]. Similarly, BRCA1 mutant
mouse cells display decreased expression of MAD2/MAD2L1, BUB1, BUBR1, and ZW10 [54,100]. Thus,
besides its moonlighting role at centrosomes, BRCA1 also controls SAC by regulating transcription of
its major components.
The WT1 TF and the TIF1γ/TRIM33 transcriptional intermediary factor are both functioning
in the SAC-Anaphase Promoting Complex (APC/C) machinery, but while WT1 is likely to have a
moonlighting function, TIF1γ does not fit all three criteria to be considered a moonlighting protein
(Table 1). WT1 co-localizes and directly interacts with MAD2 throughout mitosis, and has high affinity
for the active closed MAD2 conformation in human cells. RNAi-mediated knockout of WT1 enhances
turnover of the APC/C target securin (PTTG1), leading to an accelerated metaphase-to-anaphase
transition and defects in chromosome segregation. Consistent with a direct mitotic role, WT1 loss
does not significantly affect the expression of genes involved in SAC and APC/C regulation [101,102].
TIF1γ physically interacts with the APC/C and its CDC20 co-factor; TIF1γ knockdown in HeLa cells
negatively regulates the E3 ubiquitin ligase activity of APC/C, causing inappropriate presence of cyclin
A at metaphase, chromosome misalignment, and delay in anaphase onset [103,104]. Thus, WT1 and
TIF1γ play opposite functions in the SAC-APC/C system, with WT1 delaying and TIF1γ accelerating
metaphase-to-anaphase transition.
2.6. Mitotic and Meiotic Roles of the TFIIH Complex Components
TFIIH is an evolutionarily conserved multi-subunit complex required for transcription initiation.
In humans, TFIIH consists of a seven-subunit core complex formed by XPB/ERCC3, p62/GTF2H1,
p52/GTF2H4, p44/GTF2H2, p34/GTF2H3, p8/GTF2H5, and XPD/ERCC2, and a three-protein
subcomplex including the CDK7 kinase, cyclin H (CCNH), and MAT1/MNAT1. Mutations in
XPB, XPD, and p8 lead to genetic diseases such as xeroderma pigmentosum, Cockayne syndrome,
and trichothiodystrophy. XPD and XPB are not only involved in transcription, but also play direct
functions in nucleotide excision repair (NER) [105–107].
Certain TFIIH subunits play roles in cell division. The first indication of a role of XPB in spindle
formation came from studies on the haywire (hay) gene, which encodes the Drosophila ortholog of
XPB [108]. A specific mutant allele of hay fails to complement mutations in the testis-specific β2-tubulin
gene, which maps to a separate locus. In addition, males homozygous for this allele display defects in
meiotic spindles, suggesting a role of hay in spindle assembly [108–110]. XPB has been also implicated
in mammalian cell mitosis. XPB localizes to the centrosomes in both monkey and human cells and
co-immunoprecipitates with γ-tubulin, but the functional significance of this localization has not been
investigated [111].
Another TFIIH subunit with a potential mitotic role is XPD. XPD is also part of a five-protein
complex independent of TFIIH that includes MMS19, MIP18/CIAO2B, CIAO1, and ANT2/SLC25A5.
XPD, MMS19, and MIP18 localize to the mitotic spindle of human cells and RNAi-mediated depletion
of each of these proteins results in monopolar and multipolar spindles, and in multinucleated cells [112].
Notably, fibroblasts derived from patients with certainXPDmutations show the same mitotic phenotype
observed in HeLa XPD RNAi cells [112]. However, these results do not exclude the possibility that XPD
deficiency might result in subtle defects in transcription leading to abnormal mitotic division [112].
The mitotic roles of the TFIIH subunits have been also analyzed in the Drosophila embryo system.
Studies using fluorescently tagged TFIIH components have shown that Hay, p8, p52, and Cdk7 exhibit
similar localization patterns in live early embryos. These proteins are enriched around the metaphase
chromosomes and in some cases (e.g., p52) they appear to concentrate in a region corresponding to
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the spindle [113]. Moreover, in embryos from p8 and hay mutant mothers or Cdk7 RNAi mothers,
most spindles are morphologically aberrant and show abnormal chromosome segregation [113].
Drosophila Xpd is required for proper spindle dynamics and chromosome segregation in early embryos.
It has been suggested that loss of Xpd results in faulty localization of Cdk7, which is thought to cause
mitotic defects [114].
In summary, while there are several indications that some TFIIH components might have direct
mitotic roles in both humans and Drosophila, a solid proof is still lacking. Perhaps, the most compelling
evidence for a moonlighting function of a TFIIH subunit is provided by the studies on the Drosophila
hay (XPB) gene, which genetically interacts with the β2-tubulin gene and functions in meiotic spindle
formation in males.
2.7. Mitotic Functions of the KANSL and NSL Complexes
The nonspecific lethal (NSL) complex is a highly conserved multiprotein assembly that regulates
gene transcription in both Drosophila and mammals. The human NSL complex, also called
KAT8-associated nonspecific lethal (KANSL), comprises 8 proteins (KANSL1, KANSL2, KANSL3,
MCRS1, PHF20, WDR5, HCF1/HCFC1, and OGT) that associate with the MOF/KAT8 acetyltransferase
to regulate transcription of a specific set of genes and contribute to stem cell identity [115–117].
The Drosophila NSL complex contains at least six evolutionarily conserved Mof-associated proteins,
namely, Nsl1 (KANSL1), Dgt1 (KANSL2), Rcd1 (KANSL3), Rcd5 (MCRS1), MBD-R2 (PHF20), and Wds
(WDR5). The Drosophila genome also harbors the HCF1 and OGT orthologs, but it is currently unknown
whether the protein products of these genes are complexed with the NSL subunits [117]. The Drosophila
NSL complex acts as a major transcriptional regulator; its subunits bind to the promoters of more than
4000 housekeeping genes, although they appear to regulate transcription of only a subset of these
genes [118,119].
The components of the human and Drosophila NSL complexes appear to have direct and indirect
mitotic functions, providing insight into how transcription factors evolved moonlighting mitotic
functions. KANSL1 and KANSL3 localize to the spindles of HeLa cells and are particularly enriched at
the spindle poles. Consistent with this localization, KANSL3, and to a lesser extent KANSL1, bind
the MT minus ends in vitro; MCRS1 does not bind the MT minus ends and is recruited to the spindle
poles through interactions with KANSL3 and KANSL1 [120,121]. Furthermore, these three proteins
physically interact with the TPX2 and MCAK/KIF2C spindle assembly factors. Depletion of each of the
three proteins destabilizes the kinetochore fibers (the MT bundles that extend from the kinetochores to
the spindle poles), resulting in chromosome misalignment and faulty segregation [120,121]. These
data strongly suggest that KANSL1, KANSL3, and MCRS1 form a complex that associates with the
spindle MT minus ends and directly controls spindle assembly and functioning (Table 1).
Besides being present in the KANSL complex, WDR5 also associates with the MLLN and MLLC
subunits of the proteolytically cleaved mixed-lineage leukemia 1 (MLL1/KMT2A) protein, forming a
complex with methyltransferase activity that catalyzes trimethylation of histone H3 lysine 4 (H3K4)
and positively regulates gene expression [122,123]. The two MLL1 subunits and WDR5 localize to the
centrosomes, the spindle, the central spindle, and the midbody dark zone in human cells [124–126]
(Figure 1). WDR5 also interacts with the MT depolymerase KIF2A, promoting its localization to the
spindle poles [125], and with several midbody proteins required for cytokinesis, including PRC1,
CEP55, and the centralspindlin components MKLP1/KIF23 and CYK4/RACGAP1 [124]. Consistent
with its localization and biochemical interactions, RNAi-mediated depletion of WDR5 results in
morphologically abnormal and elongated spindles, aberrant chromosome behavior and segregation,
and failures in cytokinesis [124,125]. Collectively, these results indicate a moonlighting mitotic role for
WDR5, but this role does not appear to be the same as that played by KANSL1, KANSL3, and MCRS1.
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The Drosophila components of the NSL complex are also implicated in cell division, but they do not
appear to serve major moonlighting functions during mitosis. Genome-wide RNAi screens performed
in S2 cells showed that Dgt1 (KANSL2) is required for γ-tubulin recruitment to centrosomes [17], while
Rcd1 (KANSL3) and Rcd5 (MCRS1) are required for centriole duplication, and both centriole duplication
and PCM recruitment at the centrosomes, respectively [18]. Another RNAi-based screen in S2 cells
showed that both Rcd1 and MBD-R2 (PHF20) are required for mitotic chromosome segregation [19].
However, these studies did not determine the mitotic localization of Dgt1, Rcd1, Rcd5, and MBD-R2,
nor addressed the mechanisms leading to the mitotic phenotypes elicited by depletion of these proteins.
These issues have been addressed in a more recent study that analyzed in greater detail the
mitotic functions of Rcd1, Rcd5, MBD-R2, and Wds (WDR5) [127]. Expression of GFP-tagged forms
of these proteins in S2 cells revealed that they are all restricted to the nucleus during interphase, but
relocate to specific mitotic structures during mitosis. Both Rcd1-GFP and Rcd5-GFP accumulate at
the centrosomes and the midbody and are excluded from the chromosomes, but while Rcd5-GFP
accumulates in the midbody dark zone, Rcd1-GFP is enriched in the central spindles and in midbody
flanking regions. In contrast, MBD-R2-GFP is exclusively enriched at the mitotic chromosomes, while
Wds-GFP exhibits multiple localizations, namely, the centrosomes, the kinetochores of metaphase
chromosomes, the midbody dark zone, and a discrete region of a specific chromosome [127] (Figure 1).
Despite their different localization patterns, RNAi-mediated depletion of Rcd1, Rcd5, MBD-R2, or Wds
results in identical mitotic defects, although the frequency of these defects is lower in Wds-deficient
cells. Cells depleted of each of these proteins show fewer centrosomes than control cells, suggesting a
defect in centriole duplication. In addition, the same cells display frequent failures in chromosome
alignment and segregation. This latter phenotype has been attributed to reduction of the levels of both
Cid (CENP-A) and Ndc80 [127]. Cid is a centromere-specific histone variant required for kinetochore
assembly [128] and Ndc80 is the subunit of the kinetochore complex that binds to the spindle MTs [129].
Consistent with these phenotypes, transcription of many genes encoding centromere/kinetochore
proteins (e.g., cid, Mis12, and Nnf1b), or involved in centriole duplication (e.g., Sas-6, Sas-4, and asl) is
strongly reduced in Rcd1, Rcd5, and MBD-R2 RNAi cells, and to a lesser extent in wds RNAi cells [127].
These results suggest that the mitotic functions of Rcd1, Rcd5, MBD-R2, and Wds are mostly indirect,
with these proteins working together in interphase to stimulate transcription of genes required for
centrosome duplication and kinetochore assembly (Table 1).
In summary, the studies on the human NSL/KANSL complex revealed that four components of
this complex, KANSL1, KANSL3, MCRS1, and WDR5, meet our criteria to be genuine moonlighting
proteins during mitosis; namely, they localize to specific mitotic structures, they biochemically interact
with proteins enriched in these structures, and their depletion leads to defects in the same structures.
However, the studies on human cells did not determine whether KANSL1, KANSL3, MCRS1, or WDR5
depletion leads to reduced transcription of critical mitotic genes, and it cannot therefore be excluded
that these proteins could also have some indirect transcription-related mitotic roles. Conversely,
the Rcd1, Rcd5, MBD-R2, and Wds components of the Drosophila NSL complex do not fit our criteria to
be regarded as moonlighting proteins with mitotic functions, and instead appear to control cell division
primarily through the transcriptional regulation of mitotic genes. However, it cannot be excluded that
these NSL subunits have some minor direct mitotic functions that were not detected because they are
redundant or phenotypically masked by the strong defects caused by reduced transcription of critical
mitotic genes (Table 1).
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Table 1. Mitotic roles of transcription factors.
Name
(Organism)
Mitotic
Localization
Interacting
Mitotic Proteins Loss-of-Function Mitotic Phenotype
Mitotic Function
(Role in Cancer)
Sak1, Fkh2 (Sp) ND ND Regulate mitotic gene transcription.Defective septation [24]. Indirect
FKHRL1/FOXO3
(h) ND ND
Regulates mitotic gene transcription.
Defective mitotic exit and cytokinesis [23]. Indirect (TS)
Zas1 (Sp) Chromosomes ND
Regulates mitotic gene transcription.
Defective chromosome condensation and
segregation [25].
Indirect
ERG (h) RNA processingbodies (PBs) ND
Degrades AURKA and AURKB mRNAs.
Multipolar spindles and aberrant spindle
structure [26].
Indirect (TP)
BRCA1 (h) Not relevant Not relevant
Regulates transcription of multiple
mitotic genes, including BUB1,
BUBR1/BUB1B, AURKA, ESPL1, PTTG1,
ASPM, PRC1, and PLK1 [99].
Indirect (TS)
BRCA1 (m) Not relevant Not relevant
Regulates SAC gene transcription,
including MAD2, BUB1, BUBR1, and
ZW10 [54,100].
Indirect (TS)
BRCA1 (h) Centrosomes γ-tubulin Centrosome amplification andfragmentation [31–37]. DIRECT (TS)
BRCA1 (Xe) Spindle poles TPX2, NuMa,XRHAMM
Morphologically abnormal spindles in
BRCA1-immunodepleted Xenopus egg
extracts [40].
DIRECT
ATF5 (h)
Centrosomes
(mother centriole)
Midbody DZ
γ-tubulin,
PCNT
Defective accumulation of PCM;
centriolar fragmentation, multipolar
spindles; unknown function at the
midbody [44,45].
DIRECT
AKNA (m) Centrosomes(mother centriole)
γTuRC, EB1,
DCTN1
Defective centrosome-driven MT
regrowth after MT depolymerization [49]. DIRECT
YB-1/YBX1 (h) CentrosomesSpindle poles γ-tubulin, PCNT
Structurally abnormal centrosomes with
reduced MT nucleation ability [50,51]. DIRECT (TP)
OCT1/POU2F1 (h)
Interacts with
BRCA1
Centrosomes
Kinetochores
Midbody DZ
PARP-1,
APC1
Abnormal mitosis; unknown function at
the midbody [52–55]. DIRECT (TP)
Oct1 (Xe) ND ND
Morphologically abnormal spindles in
Oct1-immunodepleted Xenopus egg
extracts [52].
DIRECT
Nubbin (Dm)
(OCT1 ortholog)
Central spindle
Midbody FR ND Unknown function at the midbody [56]. P-direct ND
p53/TP53 (h) Centrosomes ND Centrosome amplification andfragmentation [60,61,65–67]. P-direct (TS)
p53 (m) Centrosomes ND Centrosome amplification [58,62–64]. P-direct
SP1 (h) Centrosomes ND Centrosome amplification and decreasedcentrosome-driven MT nucleation [68]. P-direct (TP)
SP1 (m) Centrosomes ND Centrosome amplification and decreasedcentrosome-driven MT nucleation [68]. P-direct
SF-1/NR5A1 (m) Centrosomes ND Centrosome amplification [69,70]. P-direct
Kaiso/ZBTB33 (h)
Centrosomes
Spindle
Central spindle
Midbody FR
γ-tubulin,
PCNT No obvious mitotic defects [71,72]. P-direct MR (TS)
CTCF (h)
Interacts with
Kaiso
Centrosomes
Spindle poles
Midbody DZ
ND Mitotic phenotype not investigated[73,74]. P-direct ND (TS)
SNAP45/SNAPC2
(h)
Centrosomes
Spindle poles
Midbody FR
ND Multiple mitotic defects; defectivechromosome condensation [75]. P-direct
ELK1 (h)
Centrosomes
Spindle
Central spindle
Midbody FR
AURKA No obvious mitotic defects [20,76]. P-direct MR (TP,TS)
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Name
(Organism)
Mitotic
Localization
Interacting
Mitotic Proteins Loss-of-Function Mitotic Phenotype
Mitotic Function
(Role in Cancer)
RUNX1 (h) Not relevant Not relevant Regulates transcription of BUBR1, BUB1,and NEK6 [78]. Indirect (TP)
RUNX1, RUNX2,
RUNX3 (h)
Centrosomes
Spindle
Midbody FR
γ-tubulin,
rootletin
Reduced cyclin B1 accumulation and
delayed mitotic entry. No specific mitotic
defects [79,80].
P-direct MR (TP)
CBFβ/CBFB (h)
Binds RUNX
proteins
Midbody FR MRLC3
Defective midbody structure and
cytokinesis (abscission); polyploid cells
[88].
DIRECT (TS, TP)
YAP/YAP1 (h)
Binds RUNX
proteins
Midbody DZ PATJ Defective cytokinesis (abscission) [90]. DIRECT (TS, TP)
Aire (m)
(AIRE in humans)
Spindle
Central spindle
AURKB, CEP55,
CNTROB, HAUS5,
HAUS8, CLASP1,
CLASP2
Abnormal spindle poles and centrosome
amplification [94]. DIRECT
HDAC3 (h)
(in complex with
NCOR1, TBL1X
and TBL1XR1)
Spindle ND Morphologically abnormal spindles andchromosome misalignment [96]. P-direct (TP)
Egr3 (m) Meiotic spindles ofmouse females ND Meiotic phenotype not investigated [97]. P-direct ND
TFIIB (m)
(GTF2B in humans)
Meiotic spindles of
mouse females ND
Morphologically abnormal spindles and
chromosomes misalignment after
antibody injection [98].
P-direct
WT1 (h)
Kinetochores
(colocalizes with
MAD2)
MAD2
Accelerated metaphase-to-anaphase
transition; defective chromosome
segregation [101,102].
DIRECT (TS, TP)
TIF1γ/TRIM33 (h) ND CDC20,APC/C
Chromosome misalignment; delay in
metaphase-to-anaphase transition
[103,104].
P-direct (TS, TP)
XPB/ERCC3 (h)
(TFIIH subunit)
Centrosomes
Spindle poles γ-tubulin Mitotic phenotype not investigated [111]. Direct ND (TS)
Hay (Dm)
(TFIIH subunit,
orthologous to
XPB)
Chromosome/
spindle area in
embryos
Testis-specific
β2-tubulin
Defective meiotic spindles in males;
abnormal mitotic spindles and defective
chromosome segregation in embryos
from hay mutant mothers [108–110,113].
P-direct
p8, p52, Cdk7 (Dm)
(TFIIH subunits)
Chromosome/
spindle area in
embryos
ND
Abnormal mitotic spindles and defective
chromosome segregation in embryos
from mutant or RNAi mothers [113].
P-direct
XPD/ERCC2 (h)
(TFIIH subunit
forms another
complex with
MIP18 and
MMS19)
Spindle
(with MIP18 and
MMS19)
ND Multipolar spindles and multinucleatedcells [112]. P-direct
Xpd (Dm)
(TFIIH subunit) ND
Regulates Cdk7
localization
Abnormal mitotic spindles and defective
chromosome segregation in embryos
from Xpd mutant mothers [114].
P-direct
KANSL1, KANSL3,
MCRS1 (h)
(KANSL complex
subunits)
Spindle poles;
KANSL1 and
KANSL3 bind MT
minus ends
TPX2,
MCAK
Chromosome misalignment and defective
segregation [120,121]. DIRECT (TP)
WDR5 (h)
(KANSL subunit
that forms another
complex with
MLL1/KMT2A)
Centrosomes
Spindle
Central spindle
Midbody DZ
KIF2A,
PRC1,
MKLP1, CYK4,
CEP55
Morphologically abnormal and elongated
spindles, aberrant chromosome
segregation, and failures in cytokinesis
[124–126].
DIRECT (TP)
Dgt1 (Dm)
(NSL subunit
orthologous to
KANSL2)
Diffuse
(weak on spindle) ND
Diminished γ-tubulin at centrosomes;
long spindles [17]. P-direct
Rcd1 (Dm)
(NSL subunit
orthologous to
KANSL3)
Centrosomes
Central spindle
Midbody FR
ND
Defective centriole replication; frequent
failures in chromosome alignment and
segregation [18,19,127].
Indirect (P-direct
MR)
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Mitotic
Localization
Interacting
Mitotic Proteins Loss-of-Function Mitotic Phenotype
Mitotic Function
(Role in Cancer)
Rcd5 (Dm)
(NSL subunit
orthologous to
MCRS1)
Centrosomes
Midbody DZ ND
Defective centriole replication; frequent
failures in chromosome alignment and
segregation [17,18,127].
Indirect (P-direct
MR)
MBD-R2 (Dm)
(NSL subunit
orthologous to
PHF20)
Chromosomes ND
Defective centriole replication; frequent
failures in chromosome alignment and
segregation [19,127].
Indirect (P-direct
MR)
Wds (Dm)
(NSL subunit
orthologous to
WDR5)
Centrosomes
Kinetochores
Midbody DZ
ND
Defective centriole replication; frequent
failures in chromosome alignment and
segregation [127].
Indirect (P-direct
MR)
Name: Each human TF is designated either with its HUGO acronym only, or both the name used in the cited papers
and the HUGO acronym. Organism: h, human; m, mouse; Dm, Drosophila melanogaster, Sp., Schizosaccharomyces
pombe, Xe, Xenopus egg extracts. Mitotic localization: ND, not determined; Midbody DZ, midbody dark zone;
Midbody FR, midbody flanking regions; localization to specific midbody regions has been decided based on the
examination of published microphotographs. Interacting mitotic proteins: ND, not determined. Mitotic function:
Indirect, controls transcription of mitotic genes; DIRECT, in addition to a role in transcription has a direct role in
mitosis, namely it is a moonlighting protein that meets the 3 criteria specified in the text. P-direct, putatively direct,
does not meet the 3 criteria but (in the cited papers) is thought to have a direct mitotic role. P-direct ND, localizes to
a mitotic structure but its mitotic role has not been investigated. P-direct MR, localizes to a mitotic structure but its
loss does not result in a detectable mitotic phenotype; it might therefore have either a minor or a redundant mitotic
function. Role in cancer was determined by examination of the pertinent literature; references are not reported: TS,
tumor suppressor; TP, tumor promoter; TS, TP, can function either as a tumor suppressor or promoter, depending
on the cellular context.
3. Mitotic Functions of Splicing Factors (SFs)
RNAi-based genome-wide screens carried out both in Drosophila and human cells have identified
many different SFs that are required for mitotic division [15–17,19,20] (Table S2). However, only a few
of these SFs have been sufficiently characterized to determine whether they have a direct mitotic role
or are instead controlling the splicing of mitotic pre-mRNAs (Table 2).
3.1. SFs with Indirect Mitotic Functions
An evolutionarily conserved SF that affects mitosis indirectly is encoded by the S. cerevisiae cef1
gene. In cef1 mutants, the single intron of the α-tubulin gene is not properly removed, resulting in
reduction of the tubulin level and disruption of spindle assembly. Cells containing an intronless
α-tubulin gene are resistant to cef1 mutations, confirming that the splicing defect is responsible for the
phenotype [130]. An indirect role of SFs in mitotic division is also suggested by studies on human
U2AF35/U2AF1. HeLa cells treated with U2AF35 siRNAs exhibit strong defects in spindle morphology
and chromosome segregation; these defects have been attributed to defective splicing of the pre-mRNA
encoding the CDC27 component of the APC/C complex. The localization of U2AF35 during mitosis
has not been investigated [131].
SON is another SF that does not appear to localize to mitotic structures; its depletion in HeLa
cells causes failures of centrosome migration to the opposite cell poles during prophase, and defective
chromosome alignment and segregation. These defects were ascribed to inadequate RNA splicing of a
specific set of genes, including those encoding
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reduction of the tubulin level and disruption of spindle assembly. Cells containing an intronless 
α-tubuli  gene are resista t to cef1 uta ions, confirming that he splici g d fect is responsible for 
the phenotype [130]. An indirect r le of SFs in mitotic division is al o suggested by studies on 
human U2AF35/U2AF1. HeLa cells treated with U2AF35 siRNAs xhibit trong defects in spindle 
morphol gy and chromosome segr gation; these defects have be n attributed to defective splicing 
of the pre-mRNA encoding the CDC27 component of the APC/C complex. The localization of 
U2AF35 during mitosis has not been investigated [131]. 
SON is another SF that does not appear to localize to mitotic structures; its depletion in HeLa 
c lls causes failures of centrosome migrat on to the opposite cell oles during prophase, and 
defective chro osom  ali nment and segregation. These d fects wer  ascribed to inadequate RNA 
splicing of a specific set of gen s, including those encoding ɣ -tubulin and the ɣ TuRC component 
TUBGCP2 [132]. WBP11 and NRDE2 are two dditional SFs that indirectly control centrosome 
behavior. WBP11 depletion in human c lls results in the ret ntion of multiple introns in the 
TUBGCP6 mRNA that specifies another ɣTuRC comp nent, leading o defective centriole 
uplication. This d fect is partially escued by an intronle s TUBGCP6 transgene, supporting the 
idea that WBP11 controls centriole behavior indirectly [133]. NRDE2 is a human SF whose depletion 
results in defective splicing of the pre-mRNA encoding the centrosomal protein CEP131. Reduction 
of the CEP131 level impairs recruitment of proteins such as AURKA, γ-tubulin, and CEP192 to the 
c ntros m s, and leads t  defective chromosome segregat on. During mitosi , NRDE2 is diffuse in 
the cy plasm and fails to accumula e in any mitotic structure [134]. 
3.2. SFs That Cont ol Cohesin Behavior 
In 2014, work from four different research groups led to the identificati  of 27 SFs that control 
sister chromatid coh sion in human cells [135–138]. The multi-subunit c he in complex holds the 
TuRC component TUBG P2 [132].
WBP11 and NRDE2 are two additional SFs that indirectly control centrosome behavior. WBP11
depletion in human cells results in the retention of multiple introns in the TUBGCP6 mRNA that
specifies another
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(P-direc  
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Name: Each human TF is designated either with its HUGO acrony  only, r both the name use  in 
the cited papers and the HUGO acronym. Organism: h, human; m, m use; D ,  
Drosophila melanogaster, Sp., Schizosaccharomyces pombe, Xe, Xe opus egg extracts. Mitotic l calization: 
ND, not determined; Midbody DZ, midbody dark z e; Midbody FR, midbody flanki g regi ns; 
localization to specific midbody regio s has bee  decided based on the examination f published 
microphotographs. Interacting mitotic proteins: ND, not etermined. Mitotic function: Indirect, 
controls transcription of mitotic genes; DIRECT, in ad ition t  a r le in transcripti n has a direct 
role in mitosis, namely it is a moonlighting protein that meets the 3 criteria specified in the text. 
P-direct, putatively direct, does not meet the 3 criteria but (in the cited papers) is thought to have a 
direct mitotic role. P-direct ND, localizes to a mitotic structure but its mitotic role as ot been 
investigated. P-direct MR, localizes t  a mitotic structure but its loss does not result in a detectable 
mitotic phenotype; it might therefore have either a minor or a redundant mitotic function. Role in 
cancer was determined by examination of the pertinent literature; references are not reported: TS, 
tumor suppressor; TP, tumor promoter; TS, TP, can function either as a tumor suppressor or 
promoter, depending on the cellular context. 
3. Mitotic Functions of Splicing Factors (SFs) 
RNAi-based genome-wide screens carried out both i  Drosophila nd human cells have 
identified many different SFs that are required for mitotic division [15–17,19,20] (Table S2). 
However, only a few of these SFs have been sufficiently characterized to determine whether they 
have a direct mitotic role or are instead controlling the splicing of mitotic pre-mRNAs (Table 2). 
3.1. SFs with Indirect Mitotic Functions 
An evolutionarily conserved SF that affects mitosis indir ctly is encoded by the S. cerevisia cef1 
gene. In cef1 mutants, the singl  intron of the α-tubulin gene is n t properly oved, resulti g in 
reduction of the tubulin level and disruption of spi dl  assembly. C lls containing n intronl ss 
α-tubulin gene are resistant to cef1 mutations, confir ing th t th  splicing d fect is responsi l  for 
the phenotype [130]. An indirect role of SFs in mitot c division is also sugg sted by studies on 
human U2AF35/U2AF1. HeLa cells treated with U2AF35 siRNAs exhib t s rong defects in spindle 
morphology and chromosome segregation; thes  defects have be n attribu ed to defective splicing 
of the pre-mRNA encoding the CDC27 component of he APC/C complex. T l calization of 
U2AF35 during mitosis has not b en investigate  [131]. 
SON is another SF that does not appear to localize to mitotic structures; it  dep etio  in HeLa 
cells causes failures of centrosome migration to the opposite cell poles during propha e, nd 
defective chromosome alignment and segregation. These defects were ascrib d to inadequat  RNA 
splicing of a specific set of genes, including those encoding ɣ -tubulin and the ɣ TuRC c mponent 
TUBGCP2 [132]. WBP11 and NRDE2 are two additional SFs that indirectly co l c ntrosome 
behavior. WBP11 depletion n human cells results in the r tention of multiple intr ns in the
TUBGCP6 mRNA that specifies a other ɣTuRC compon nt, leadi to efec ive centri le 
duplication. This defect is partially rescued by an intronless TUBGCP6 transgene, supporting the 
idea that WBP11 controls centriole behavior in irectly [133]. NRDE2 is a human SF w ose deplet on
results in defective splicing of the pre-mRNA encoding the centrosom l protein CEP131. Reduction 
of the CEP131 level impairs recruitment of proteins such as AURKA, γ-tubulin, and CEP192 to the 
centrosomes, and leads to defective chromosome segregation. During mitosis, NRDE2 is diffuse in 
the cytoplasm and fails to accumulate in any mitotic structure [134]. 
3.2. SFs That Control Cohesin Behavior 
In 2014, work from four different research groups led to the identification of 27 SFs that control 
sister chromatid cohesion in human cells [135–138]. The multi-subunit cohesin complex holds the 
TuRC component, leading to defective centriole duplication. This defect is partially
rescued by an intronless TUBGCP6 transgene, supporting the idea that WBP11 controls centriole
behavior indirectly [133]. NRDE2 is a human SF whose depletion results in defective splicing of
the pre-mRNA encoding the centrosomal protein CEP131. Reduction of the CEP131 level impairs
recruit ent of proteins such as AURKA, γ-tubulin, and CEP192 to the centrosomes, and leads to
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defective chromosome segregation. During mitosis, NRDE2 is diffuse in the cytoplasm and fails to
accumulate in any mitotic structure [134].
3.2. SFs That Control Cohesin Behavior
In 2014, work from four different research groups led to the identification of 27 SFs that control
sister chromatid cohesion in human cells [135–138]. The multi-subunit cohesin complex holds the
sister chromatids together until anaphase, ensuring a faithful chromosome segregation. Cohesin
associates with DNA following replication, and this association is stabilized by sororin/CDCA5
that antagonizes WAPL, a protein that is able to release cohesin from DNA, thereby allowing sister
chromatid separation [139]. Seven of the 27 SFs affecting cohesin behavior have been analyzed in
detail: NHP2L1/SNU13, SART1, MFAP1, CDC5L, SNW1, PRP19/PRPF19, and UBL5. RNAi-mediated
depletion of each of these SFs in human cells resulted in metaphase chromosomes with parallel sister
chromatids, anaphase delay, and defective chromosome segregation. Transcript analysis revealed that
depletion of these factors results in intron retention in the sororin mRNA, but not in mRNAs encoding
cohesin subunits. Accordingly, the SF-dependent mitotic defect was partially restored by either the
expression of an intronless sororin transgene or RNAi against WAPL. These results suggest that many
SFs mediate sister chromatid cohesion indirectly, predominantly by catalyzing splicing of the sororin
pre-mRNA [135–138].
However, since the phenotypic rescue elicited by intronless sororin expression is often incomplete,
SFs might contribute to sister chromatid cohesion in some sororin-independent way. One possibility
is that SFs directly regulate cohesin association with the chromosomes, as suggested by recent work
showing that many SFs physically interact with cohesin [140]. Each of the 11 known components of
cohesin was tagged with a dual FLAG-SBP peptide and expressed in cultured human cells; dual affinity
purification followed by mass spectrometry revealed that the cohesin subunits copurify with a large
number of SFs, including some SFs that were previously shown to be required for sister chromatid
cohesion [136]. Furthermore, it has been demonstrated that in human cells, the cohesin subunit STAG2
and some of its interacting SFs (HNRNPH/HNRNPH1, EFTUD2, and SF3B1) precisely colocalize
throughout the cell cycle [140]. In conclusion, while it is likely that several SFs control cohesin
behavior primarily through the regulation of sororin pre-mRNA splicing, the robust physical interaction
between cohesin and SFs raises the concrete possibility that some SFs contribute directly to sister
chromatid cohesion.
3.3. The Indirect and Direct Mitotic Functions of the PRP19 Complex
The PRP19 complex (also known as nineteen complex or NTC) is a multifunctional protein
assembly that has a conserved core of four subunits (PRP19/PRPF19, CDC5L, SPF27/BCAS2, and
PLRG1). Besides splicing, this complex has been implicated in several additional processes, including
DNA damage response and protein ubiquitination [141,142]. The PRP19 complex is also involved
in mitosis, where it appears to play both indirect and direct functions. RNAi-mediated depletion of
each component of the complex in human cells impairs kinetochore-MT attachment, causing frequent
failures in chromosome segregation [143]. These mitotic aberrations are attributed to defective splicing
of mitotic genes such as those that encode the dynein-dynactin components DYNC1H1, DYNLRB2,
and DCTN4, which are required for proper kinetochore-microtubule attachment [143].
As already mentioned, other studies showed that PRP19- and CDC5L-depleted human cells
exhibit reduced cohesion between sister chromatids, and that this defect is rescued by the expression
of an intronless sororin gene [136,138]. However, the same cells, in addition to the cohesion defect,
display morphologically abnormal mitotic spindles. These aberrant spindles are still present in cells
expressing intronless sororin and are not observed in cells depleted of cohesin subunits [138], suggesting
a cohesin-independent requirement of the PRP19 complex for spindle assembly.
There is an additional study that points to a splicing-independent, direct mitotic role of the
PRP19 complex [42]. siRNA-mediated knockdown of SPF27 in HeLa cells leads to downregulation
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of the other components of the PRP19 complex and to a severe defect in end-on attachment of MTs
to the kinetochores [42], consistent with the results of Mu and coauthors (2014) [143]. Moreover,
an investigation of the role of the PRP19 complex in spindle assembly around sperm nuclei in Xenopus
egg extracts suggests a direct mitotic function. Xenopus extracts immunodepleted of either the PRP19
or the SPF27 ortholog produce spindles with reduced MT density in the central part, suggesting a
defect in the interaction between the sperm chromatin and the spindle MTs [42]. These results argue
strongly for a moonlighting, splicing-independent mitotic function of the PRP19 complex because,
as mentioned earlier, Xenopus egg extracts can form a spindle in the complete absence of transcription
or translation of any mRNA, except cyclin B.
Collectively, these results suggest a dual mitotic function for the PRP19 complex, an indirect
function required for splicing of pre-mRNAs encoding sororin and some dynein-dynactin components
and a direct, as yet undefined function in mitotic spindle assembly.
3.4. SFs with Roles in the SAC and in Kinetochore-MT Interactions
A protein involved in pre-mRNA splicing that is also required for SAC activity in human cells
is the PRP4/PRPF4 kinase. PRP4 is required for pre-mRNA splicing in S. pombe [144] and tightly
associates with U4/U6 snRNP in human cells [145,146]. PRP4 accumulates on the kinetochores of
HeLa cells and mediates recruitment of SAC proteins such as MPS1/IDUA, MAD1/MAD1L1, and
MAD2 to kinetochores, but there is no evidence of physical interaction between PRP4 and these
SAC components [147]. PRP4 depletion results in precocious anaphase onset, lagging anaphase
chromosomes, and aneuploidy, indicating that PRP4 deficiency compromises SAC activity [147]. Thus,
PRP4 does not fit all three criteria to be considered a moonlighting protein. However, in PRP4-depleted
cells, the biogenesis of SAC proteins such as BUBR1/BUB1B, MAD1, MAD2, and MPS1 is not affected,
suggesting a direct role of PRP4 in the SAC machinery [147].
Studies in Drosophila and human cells have recently suggested that the conserved spliceosomal
components SF3A2 and PRP31 (designated as SF3A2 and PRP31/PRPF31 in humans, and Sf3A2 and
Prp31 in Drosophila) play direct mitotic roles. SF3A2 is a subunit of a conserved heterotrimeric SF3A
complex of U2 snRNP; PRP31 is a component of the U4/U6.U5 tri-snRNP complex that comprises at
least 30 proteins [148–150]. Drosophila Sf3A2 and Prp31 associate with the spindles of S2 tissue culture
cells and bind MTs in vitro [151]. The mouse ortholog of Sf3A2 was also shown to have MT binding
and bundling activities [152], suggesting that Sf3A2 plays a conserved non-canonical MT-binding
function. Furthermore, Sf3A2 and Prp31 physically interact with each other and directly bind the
components of the Drosophila Ndc80 complex (Ndc80, Mitch/Spc25, and Nuf2). Consistent with these
findings, depletion of these SFs in Drosophila cells impairs accumulation of Ndc80 at kinetochores,
leading to severe defects in chromosome alignment and segregation [151]. Comparable results were
obtained in HeLa cells where SF3A2 and PRP31 were found to interact physically with each other and
with HEC1/NDC80. In addition, experiments with synchronized cells showed that the SF3A2-HEC1
and PRP31-HEC1 interactions are restricted to the M phase of the cell cycle. Loss of either SF in HeLa
cells results in morphologically irregular spindles, defective chromosome congression at metaphase,
and reduced frequency of ana-telophases [151]. Collectively, these results suggest that SF3A2 and
PRP31 directly regulate interactions among kinetochores, spindle MTs, and the Ndc80 complex in both
Drosophila and human cells.
Further strong evidence for a direct mitotic role of Sf3A2 and Prp31 is provided by the results
of antibody injections into Drosophila embryos [151]. After fertilization, Drosophila syncytial embryos
undergo 13 extremely rapid nuclear divisions that predominantly rely on already spliced mRNAs
and proteins packaged into the egg by the mother, although a minor transcription wave has been
reported during cycles 8–13 [153,154]. These early transcripts require the Fandango subunit of the
Prp19 complex for splicing, but loss of Fandango does not affect syncytial mitoses, causing nuclear
defects only during the 14th cell cycle [155]. Thus, acute inactivation of a SF by antibody injection
in live early embryos (cycles 8–13) is not expected to cause splicing-dependent mitotic defects, but
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only defects reflecting a direct mitotic role of the targeted SF. Syncytial embryos injected with either
anti-Sf3A2 or anti-Prp31 antibodies shortly before nuclear envelope breakdown (NEB) display very
similar mitotic phenotypes. Mitotic divisions show a decrease in spindle length relative to controls,
defective chromosome alignment at metaphase, and frequent failures in chromosome segregation.
This phenotype is observed as early as one minute after antibody injection, ruling out the possibility of
an indirect mitotic effect of Sf3A2 and Prp31 [151]. Indeed, one minute does not appear to be sufficient
for splicing and translation of a hypothetical mitotic pre-mRNA and, most importantly, it is extremely
unlikely that the protein product of this pre-mRNA needs to be replenished every minute (Table 2).
Table 2. Mitotic roles of splicing factors.
Name
(Organism)
Mitotic
Localization
Interacting
Mitotic Proteins
Loss-of-Function Mitotic
Phenotype
Mitotic Function
(Role in Cancer)
CEF1 (Sc) ND ND
Inefficient splicing of α-tubulin
pre-mRNA. Defective spindle
assembly. Mutant phenotype
rescued by an intronless α-tubulin
gene [130].
Indirect
U2F35/U2AF1 (h) ND ND
Inefficient splicing of the CDC27
pre-mRNA. Defective spindle
morphology and chromosome
segregation [131].
Indirect (TS, TP)
SON (h) ND ND
Inefficient splicing of TUBG1,
TUBGCP2, TUBGCP4, and AKT1
pre-mRNAs. Impaired centrosome
separation at prophase; defective
chromosome segregation and
cytokinesis [132].
Indirect (TS)
WBP11 (h) ND ND
Inefficient splicing of TUBGCP6
pre-mRNA. Impaired centriole
duplication; mutant phenotype
rescued by an intronless TUBGCP6
transgene [133].
Indirect
NRDE2 (h) Diffuse in thecytoplasm ND
Inefficient splicing of CEP131
pre-mRNA. Impaired centrosomal
recruitment of γ-tubulin, AURKA,
and CEP192; defective chromosome
segregation [134].
Indirect (TS, TP)
27 different human
SFs, including
PRPF8,
NHP2L1/SNU13,
SART1, MFAP1,
CDC5L, SNW1,
PRP19/PRPF19,
UBL5, SF3B1,
SNRNP200, PRPF6
Some
colocalize
with the
Cohesin
complex
Some copurify
with the Cohesin
subunits
Intron retention in the sororin
mRNA. Parallel sister chromatids at
metaphase and defective
chromosome segregation; mutant
phenotype partially rescued by an
intronless sororin transgene
[135–138,140].
Indirect, (possibly
also DIRECT) (TP:
CDC5L, SNW1,
U2AF2)
PRP19/PRPF19 (h),
CDC5L (h),
SPF27/BCAS2 (h),
PLRG1 (h) (PRP19
complex)
Not relevant Not relevant
Inefficient splicing of DYNC1H1,
DYNLRB2, and DCTN4 pre-mRNAs.
Impaired kinetochore-MT
attachment, defective chromosome
segregation [143].
Indirect (TP:
CDC5L, BCAS2)
PRP19/PRPF19 (h),
CDC5L (h),
SPF27/BCAS2 (h)
(PRP19 complex)
Diffuse ND
Defective kinetochore-MT
interaction; abnormal spindles and
defective chromosome alignment in
human cells [42,138].
P-direct (TP:
CDC5L, BCAS2)
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Table 2. Cont.
Name
(Organism)
Mitotic
Localization
Interacting
Mitotic Proteins
Loss-of-Function Mitotic
Phenotype
Mitotic Function
(Role in Cancer)
Prp19 (Xe), Bcas2
(Xe) (PRP19
complex)
ND ND
Defective chromatin-MT interaction;
morphologically abnormal spindles
in Xenopus egg extracts [42].
DIRECT
PRP4/PRPF4 (h) Kinetochores ND
Defective recruitment at
kinetochores of the MPS1, MAD1,
and MAD2 SAC proteins.
Precocious anaphase onset; lagging
anaphase chromosomes and
aneuploidy [147].
P-direct (TP)
SF3A2 (h),
PRP31/PRPF31 (h)
Spindle
(Mouse Sf3A2
binds MTs
in vitro)
Ndc80/HEC1
Morphologically irregular spindles;
defective chromosome congression
at metaphase; reduced frequency of
ana-telophases [151,152].
DIRECT
Sf3A2 (Dm), Prp31
(Dm)
Spindle
(Binds MTs
in vitro)
Ndc80, Mitch, Nuf2
(Ndc80 complex)
Reduced accumulation of Ndc80 at
kinetochores and severe defects in
chromosome alignment and
segregation. Anti-Sf3A2 and
anti-Prp31 injections disrupt mitosis
in embryos [151].
DIRECT
Name: Each human SF is designated either with the HUGO acronym only, or both the name used in the cited
papers and the HUGO acronym. Organism: h, human; m, mouse; Dm, Drosophila melanogaster; Sc, Saccharomyces
cerevisiae; Xe, Xenopus egg extracts. Mitotic localization: ND, not determined. Interacting mitotic proteins: ND, not
determined. Mitotic function: Indirect, control splicing of mitotic gene pre-mRNAs; DIRECT, in addition to a role in
splicing has a direct role in mitosis, namely it is a moonlighting protein that meets the 3 criteria specified in the
text. P-direct, putatively direct, does not meet the 3 criteria but (in the cited papers) is thought to have a direct
mitotic role. Role in cancer was determined by examination of the pertinent literature; references are not reported:
TS, tumor suppressor; TP, tumor promoter; TS, TP, can function either as a tumor suppressor or a tumor promoter,
depending of the cellular context.
4. Conclusions and Perspectives
The studies described here implicate many transcription and splicing factors in the regulation
and proper execution of mitotic division. Several of these factors do not localize to specific mitotic
structures and appear to affect mitosis indirectly by controlling transcription or splicing of pre-mRNAs
that encode mitotic proteins. Other factors are enriched in specific mitotic structures, but the extant
data are not sufficient to establish whether they play direct mitotic functions. A third category of
factors localizes to a specific mitotic structure(s), biochemically interacts with proteins enriched in
same structure(s), and causes defects in this/these structure(s) upon depletion. We have assumed
that the TFs and SFs with these three properties play moonlighting mitotic functions besides their
canonical functions in RNA transcription or splicing. We believe that these three properties are
sufficient to conclude that a TF or a SF directly functions in mitosis. However, this conclusion would be
consolidated by the demonstration that depletion of the factor under study leads to mitotic defects in a
model system where mitosis is both transcription- and splicing-independent. As mentioned earlier,
examples of these systems are the Xenopus egg extracts immunodepleted of a specific factor [39,41,42]
and live early Drosophila embryos expressing suitable fluorescent mitotic markers injected with specific
antibodies. The latter system has the additional advantage of permitting the analysis of a large number
of synchronous mitoses within minutes from the antibody injection [151].
The extant data indicate that the moonlighting TFs and SFs are involved in diverse mitotic
processes, including (i) centriole stability, duplication, and PCM recruiting ability; (ii) centrosome- and
chromatin-driven MT nucleation; (iii) spindle formation and dynamics; (iv) kinetochore-MT interaction;
(v) spindle assembly checkpoint; and (vi) cytokinesis. Thus, it appears that most if not all steps of
mitosis are directly regulated by some TFs and/or SFs. This raises the question of how TFs and SFs
evolved direct mitotic functions. The evolution and the biological meaning of protein moonlighting
are discussed in detail in the review of Copley (2014) [4] and in the recent book by Henderson et al.
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(2017) [5]. Here, we only consider the simplest scenario, assuming than TFs and SFs gradually evolved
so as to acquire an additional mitotic function, while keeping their canonical roles in transcription
or splicing. It is likely that the TFs and SFs described here evolved a moonlighting mitotic function
through the acquisition of genetic changes that allow physical interactions with mitotic proteins, specific
posttranslational modifications, or both (Tables 1 and 2; Figure 1). In this context, it is worth noting
that published work (see Tables 1 and 2) indicates that the TFs with putative moonlighting mitotic
functions outnumber the SFs with the same functions. These data raise the question of whether TFs are
more prone than SFs to evolve additional mitotic functions. This is an unlikely possibility for at least
two reasons. First, the global number of TFs is at least five times higher than that of SFs [21,156,157].
Second, and most importantly, a simple search of the PubMed database using “transcription factors” as
query retrieved 39 times more publications than those retrieved using “splicing factors”. Thus, taking
into account that RNAi-based screens yielded more SFs than TFs (Tables S1 and S2), it is conceivable
that future work will identify many additional SFs with moonlighting mitotic functions.
Many TFs accumulate in specific mitotic structures, but there is not compelling evidence that these
accumulations are functionally relevant (Table 1; Figure 1). In addition, some conserved TFs appear to
have species-specific mitotic localizations and functions. For example, the mitotic localizations of the
human KANSL complex subunits are not identical to those of their NSL counterparts in Drosophila.
In addition, while the KANSL components appear to have integral mitotic roles, their NSL orthologs
are primarily involved in transcriptional regulation of specific mitotic genes [120,121,127]. However,
it has been suggested that the Drosophila NSL proteins might have relatively minor direct mitotic
roles that are masked by their transcription-dependent effects on cell division [127]. More in general,
we propose that most proteins that accumulate in mitotic structures have either minor moonlighting
functions or are evolving towards the acquisition of these functions. Finally, we would like to note
that the TFs and SFs with established or possible moonlighting mitotic functions ensure the fidelity of
a series of processes, whose alteration can promote carcinogenesis, namely, centrosome duplication,
kinetochore-MT interaction, spindle assembly checkpoint, and cytokinesis. Many of these factors
have been already implicated in cancer promotion or suppression (Tables 1 and 2) and their further
characterization is likely to provide additional insight into their roles in tumor development. We also
believe that identification of new TFs and SFs with moonlighting mitotic functions should be an
important goal of future studies, as a detailed understanding of the multiple mechanisms that regulate
mitotic division will be instrumental to devise new cancer therapies.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4409/9/6/1554/s1,
Table S1: Transcription factors with mitotic functions identified in large-scale RNAi screens carried out in human
and Drosophila tissue culture cells. Table S2: Splicing factors with mitotic functions identified in large-scale RNAi
screens carried out in human and Drosophila tissue culture cells.
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